MK-8245
- Generic Name
- MK-8245
- Drug Type
- Small Molecule
- Chemical Formula
- C17H16BrFN6O4
- CAS Number
- 1030612-90-8
- Unique Ingredient Identifier
- 537E7QE8LX
- Background
MK-8245 has been used in trials studying the treatment of Type 2 Diabetes Mellitus.
Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)
- First Posted Date
- 2009-09-04
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 56
- Registration Number
- NCT00972322
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245 (8245-004)(COMPLETED)
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 14
- Registration Number
- NCT00790556
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath